[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor, currently under pre-clinical development as a therapeutic for patients living with inflammatory bowel diseases, including ulcerative colitis and Crohn's disease (CD), as well as develops PALI-1908, an oral, selective PDE4 inhibitor prodrug that is locally bioactivated in the terminal ileum of CD patients, currently in the research stage. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California; a co-development and distribution agreement with Newsoara Biopharma Co., Ltd; and a transformative strategic collaboration with Strand Life Sciences for advancing precision medicine for ulcerative colitis therapy. The company is based in Carlsbad, California.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 67, "title": "CEO, CFO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 791333, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 46, "title": "COO & Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 635002, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7967, "open": 0.79, "dayLow": 0.7666, "dayHigh": 0.8199, "regularMarketPreviousClose": 0.7967, "regularMarketOpen": 0.79, "regularMarketDayLow": 0.7666, "regularMarketDayHigh": 0.8199, "payoutRatio": 0.0, "beta": 1.41, "forwardPE": -0.08711623, "volume": 84837, "regularMarketVolume": 84837, "averageVolume": 614062, "averageVolume10days": 1313240, "averageDailyVolume10Day": 1313240, "bid": 0.56, "ask": 1.01, "bidSize": 2, "askSize": 2, "marketCap": 2356471, "fiftyTwoWeekLow": 0.75, "fiftyTwoWeekHigh": 9.65, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 1.2524, "twoHundredDayAverage": 2.88075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -6633774, "profitMargins": 0.0, "floatShares": 1181634, "sharesOutstanding": 2765980, "sharesShort": 148042, "sharesShortPriorMonth": 136962, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0499, "heldPercentInsiders": 0.00796, "heldPercentInstitutions": 0.07203, "shortRatio": 0.96, "shortPercentOfFloat": 0.0537, "impliedSharesOutstanding": 2965980, "bookValue": 5.512, "priceToBook": 0.14414005, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -14065000, "trailingEps": -13.26, "forwardEps": -9.12, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": 0.461, "52WeekChange": -0.8596491, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 0.7945, "targetHighPrice": 38.0, "targetLowPrice": 8.0, "targetMeanPrice": 20.0, "targetMedianPrice": 14.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 8052000, "totalCashPerShare": 6.056, "ebitda": -14403000, "totalDebt": 357000, "quickRatio": 3.039, "currentRatio": 3.308, "totalRevenue": 0, "debtToEquity": 5.403, "revenuePerShare": 0.0, "returnOnAssets": -0.68202, "returnOnEquity": -1.35959, "grossProfits": 0, "freeCashflow": -8061875, "operatingCashflow": -12558000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketPrice": 0.7945, "regularMarketChangePercent": -0.279508, "shortName": "Palisade Bio, Inc.", "longName": "Palisade Bio, Inc.", "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1742412956, "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": -0.0022000074, "regularMarketDayRange": "0.7666 - 0.8199", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 614062, "fiftyTwoWeekLowChange": 0.044499993, "fiftyTwoWeekLowChangePercent": 0.059333324, "fiftyTwoWeekRange": "0.75 - 9.65", "fiftyTwoWeekHighChange": -8.855499, "fiftyTwoWeekHighChangePercent": -0.91766834, "fiftyTwoWeekChangePercent": -85.96491, "dividendDate": 1563408000, "earningsTimestampStart": 1742905800, "earningsTimestampEnd": 1743424200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -13.26, "epsForward": -9.12, "epsCurrentYear": -11.66333, "priceEpsCurrentYear": -0.06811948, "fiftyDayAverageChange": -0.45790005, "fiftyDayAverageChangePercent": -0.36561805, "twoHundredDayAverageChange": -2.0862498, "twoHundredDayAverageChangePercent": -0.7242037, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Seneca Biopharma, Inc.", "nameChangeDate": "2025-03-15", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]